The steep cost of Type 2: When diabetes dragged her down, she chose to fight
Mark Schutta of the Perelman School of Medicine explains why many of the newer diabetes medications are out of reach for patients and providers.
・ From USA Today
Mark Schutta of the Perelman School of Medicine explains why many of the newer diabetes medications are out of reach for patients and providers.
・ From USA Today